Paris, France

Claire Minoletti-Hochepied

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
4 patents (USPTO):

Title: Claire Minoletti-Hochepied: Innovator in Therapeutic Peptides

Introduction

Claire Minoletti-Hochepied is a prominent inventor based in Paris, France. She has made significant contributions to the field of therapeutic peptides, holding a total of 4 patents. Her work focuses on the development of biologically active peptides that have potential medicinal applications.

Latest Patents

Among her latest patents are innovative formulations of modified lipidated relaxin B chain peptides. One of her notable inventions describes a biologically active single chain relaxin peptide with the formula N-Ac-L-E-G-R-E-K-V-R-A-X-I-X-X-E-G-X-S-T-F-S-X-R-A-X-NH-C, or a salt or solvate thereof. Another patent outlines a similar peptide with the formula N-Ac-(E)-X-E-G-R-E-X-V-R-X-X-I-X-X-E-G-X-S-X-X-X-X-R-(X)-(X)-(K)-(X)-(gE)-X-C, along with a pharmaceutical composition that includes at least one peptide of the invention for use as a medicament.

Career Highlights

Claire is currently associated with Sanofi, a leading global healthcare company. Her work at Sanofi has allowed her to explore and develop groundbreaking therapeutic solutions that address various medical needs.

Collaborations

Throughout her career, Claire has collaborated with esteemed colleagues, including Olivier Duclos and Stéphane Illiano. These partnerships have contributed to her innovative research and the successful development of her patented technologies.

Conclusion

Claire Minoletti-Hochepied is a trailblazer in the field of therapeutic peptides, with a strong portfolio of patents that reflect her dedication to advancing medical science. Her contributions continue to pave the way for new therapeutic options in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…